Federal Officials Meet To Consider Fate Of Johnson & Johnson COVID-19 Vaccine

On Friday, a federal advisory panel meets to decide whether to resume the rollout of the Johnson & Johnson coronavirus vaccine. Distribution was paused after reports of extremely rare but potentially deadly blood clots.

Here & Now's Tonya Mosley speaks with Dr. Leana Wen, a professor of public health at George Washington University and emergency room physician, who argues the longer the pause goes on, the more potential harm it has.